您好,欢迎访问山东省农业科学院文献资源数据库平台

A geniposide-phospholipid complex ameliorates posthyperuricemia chronic kidney disease induced by inflammatory reactions and oxidative stress

文献类型: 外文期刊

作者: Wang, Mu-xuan 1 ; Wang, Min-min 4 ; Liu, Chao 3 ; Chen, Jia-shu 3 ; Liu, Jian-shu 1 ; Guo, Xu 3 ; Zhang, Meng-qi 3 ; Zhang, Jing 3 ; Sun, Jin-yue 3 ; Liao, Zhi-xin 1 ;

作者机构: 1.Southeast Univ, Sch Chem & Chem Engn, Dept Pharmaceut Engn, Nanjing 211189, Peoples R China

2.Southeast Univ, Jiangsu Prov Hitech Key Lab Biomed Res, Nanjing 211189, Peoples R China

3.Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Novel Food Resources Proc, Key Lab Agroprod Proc Technol Shandong Prov,Minist, Jinan 250100, Peoples R China

4.Taian Tradit Chinese Med Hosp, Tai An 271000, Peoples R China

5.Shanxi Funct Food Engn Ctr Co Ltd, Xian 710000, Peoples R China

关键词: Hyperuricemia; Chronic kidney disease; Geniposide-phospholipid complex; Inflammatory reaction; Oxidative stress

期刊名称:EUROPEAN JOURNAL OF PHARMACOLOGY ( 影响因子:5.195; 五年影响因子:4.721 )

ISSN: 0014-2999

年卷期: 2022 年 930 卷

页码:

收录情况: SCI

摘要: Hyperuricemia is a common metabolic disease and is one of the factors that could induce chronic kidney disease (CKD). Geniposide (GEN) is a typical natural iridoid glucoside compound with a series of biological activities, but the poor bioavailability of GEN limits its clinical application. In this context, the pharmacological activity of the geniposide-phospholipid complex (GEN-PLC) in ameliorating posthyperuricemia CKD was evaluated by in vitro and in vivo experiments in this study. In vitro cell experiments showed that GEN-PLC treatment markedly decreased inflammatory cytokine levels and reactive oxygen species levels compared with those of GEN in uric acid-treated HKC cells. In vivo research results confirmed that a high concentration of uric acid could cause CKD by increasing inflammatory cytokines and reactive oxygen species in hyperuricemic mice. At the same time, GEN-PLC could regulate the PI3K/AKT/NF-kappa B and Keap1/Nrf2/HO-1 signaling pathways to effectively inhibit the inflammatory response and oxidative stress, thereby ameliorating posthyperuricemia CKD, and the thera-peutic effect was better than that of GEN. In addition, the preparation technology of GEN-PLC was optimized, and the physiochemical analysis explained the intermolecular interactions of the two components. Based on the research results, GEN-PLC could enhance the bioavailability of GEN and become a promising candidate for clinical drug development.

  • 相关文献
作者其他论文 更多>>